Assessment of the potential for oritavancin MIC changes among Staphylococcus aureus nasal carriage isolates following systemic oritavancin treatment in a phase 2 study in patients with acute bacterial skin and skin-structure infections.

Authors :: Arhin FF
Moeck G
Source :: Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2017 Jun; Vol. 9, pp. 8-9. Date of Electronic Publication: 2017 Mar 06.
Publication Year :: 2017

Subjects :: Administration, Intravenous
Anti-Bacterial Agents administration & dosage
Double-Blind Method
Humans
Lipoglycopeptides administration & dosage
Microbial Sensitivity Tests
Staphylococcus aureus isolation & purification
Anti-Bacterial Agents pharmacology
Carrier State microbiology
Drug Resistance, Bacterial
Lipoglycopeptides pharmacology
Nasal Mucosa microbiology
Staphylococcal Skin Infections drug therapy
Staphylococcus aureus drug effects

Full Text Access

Tools